bluebird bio, Inc.
DelistedCIK 1293971fmd_15H3DN9C3GGSSG1TGDT1102JHHManufacturing · Biological Products, (No Diagnostic Substances)Template: Standard
Coverage: Jan 01, 2011 to Mar 31, 2025, 54 periods
Latest annual · FY2024
Millions- Total revenues
- 84
- Gross profit
- (6)
- Operating income
- (270)
- Net income
- (241)
- Free cash flow
- (263)
Latest quarter · Q1 FY2025
Millions- Total revenues
- 39
- Gross profit
- 26
- Operating income
- (25)
- Net income
- (29)
- Free cash flow
- (44)
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2021 to FY2024
- +183.9%
- Revenue, 5 yearsFY2019 to FY2024
- n/m
- Net income, 5 yearsFY2019 to FY2024
- n/m
bluebird bio, Inc. financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2024 | FY2023 | Change | Source |
|---|---|---|---|---|
| Revenue | $83.8 million | $29.5 million | +184.1% | 10-K 2025-03-27 · proof |
| Gross profit | -$5.6 million | -$4 million | 10-K 2025-03-27 · proof | |
| Operating income | -$270.5 million | -$244.3 million | 10-K 2025-03-27 · proof | |
| Net income | -$240.7 million | -$211.9 million | 10-K 2025-03-27 · proof | |
| Cash from operating activities | -$260 million | -$235 million | 10-K 2025-03-27 · proof | |
| Free cash flow | -$262.6 million | -$239.2 million | 10-K 2025-03-27 · proof | |
| Total assets | $460.2 million | $619.2 million | -25.7% | 10-K 2025-03-27 · proof |
| Total liabilities | $491.8 million | $424.6 million | +15.8% | 10-K 2025-03-27 · proof |
| Cash and cash equivalents | $62.3 million | $221.8 million | -71.9% | 10-K 2025-03-27 · proof |
- What was bluebird bio, Inc.'s revenue in fiscal 2024?
- bluebird bio, Inc. reported revenue of $83.8 million for fiscal 2024 (the year ended Dec 31, 2024), against $29.5 million the year before (+184.1%). Source: the 10-K filed with the SEC on Mar 27, 2025. SEC
- What was bluebird bio, Inc.'s gross profit in fiscal 2024?
- bluebird bio, Inc. reported gross profit of -$5.6 million for fiscal 2024 (the year ended Dec 31, 2024), against -$4 million the year before. Source: the 10-K filed with the SEC on Mar 27, 2025. SEC
- What was bluebird bio, Inc.'s operating income in fiscal 2024?
- bluebird bio, Inc. reported operating income of -$270.5 million for fiscal 2024 (the year ended Dec 31, 2024), against -$244.3 million the year before. Source: the 10-K filed with the SEC on Mar 27, 2025. SEC
- What was bluebird bio, Inc.'s net income in fiscal 2024?
- bluebird bio, Inc. reported net income of -$240.7 million for fiscal 2024 (the year ended Dec 31, 2024), against -$211.9 million the year before. Source: the 10-K filed with the SEC on Mar 27, 2025. SEC
- What was bluebird bio, Inc.'s cash from operating activities in fiscal 2024?
- bluebird bio, Inc. reported cash from operating activities of -$260 million for fiscal 2024 (the year ended Dec 31, 2024), against -$235 million the year before. Source: the 10-K filed with the SEC on Mar 27, 2025. SEC
- What was bluebird bio, Inc.'s free cash flow in fiscal 2024?
- bluebird bio, Inc. reported free cash flow of -$262.6 million for fiscal 2024 (the year ended Dec 31, 2024), against -$239.2 million the year before. Source: the 10-K filed with the SEC on Mar 27, 2025. SEC
- What are bluebird bio, Inc.'s total assets?
- As of Dec 31, 2024, bluebird bio, Inc. reported total assets of $460.2 million, against $619.2 million a year earlier (-25.7%). Source: the 10-K filed with the SEC on Mar 27, 2025. SEC
- What are bluebird bio, Inc.'s total liabilities?
- As of Dec 31, 2024, bluebird bio, Inc. reported total liabilities of $491.8 million, against $424.6 million a year earlier (+15.8%). Source: the 10-K filed with the SEC on Mar 27, 2025. SEC
- What are bluebird bio, Inc.'s cash and cash equivalents?
- As of Dec 31, 2024, bluebird bio, Inc. reported cash and cash equivalents of $62.3 million, against $221.8 million a year earlier (-71.9%). Source: the 10-K filed with the SEC on Mar 27, 2025. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1293971&period_type=annual&limit=5"Information only, not investment advice.